Key statistics
On Monday, Brainstorm Cell Therapeutics Inc (GHDN:STU) closed at 2.98, 37.92% above the 52 week low of 2.16 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.84 |
---|---|
High | 2.98 |
Low | 2.84 |
Bid | 0.1978 |
Offer | 0.222 |
Previous close | 2.98 |
Average volume | -- |
---|---|
Shares outstanding | 5.32m |
Free float | 4.84m |
P/E (TTM) | -- |
Market cap | 6.38m USD |
EPS (TTM) | -3.36 USD |
Data delayed at least 15 minutes, as of Sep 30 2024.
More ▼
Press releases
- BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting
- BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit
- BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting
- BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
More ▼